Bob Peterson will become interim CEO at Biote on June 8 [Photo: LinkedIn]
Biote (Nasdaq: BTMD), an Irving-based provider of innovative hormone optimization and healthy aging solutions, has appointed Bob Peterson, its current chief financial and business officer, as its Interim CEO and director, effective June 8. Bret Christensen is stepping down from his role as CEO and will continue to serve on the company’s board of directors.
In addition, Marc Beer, Biote’s chairman, will assume the role of executive chairman.
“The board respects Bret’s decision to step down for family and personal reasons and remains focused on maintaining disciplined operational execution and continued strategic progress,” Beer said in a statement. “We’re fortunate to have significant bench strength in Bob Peterson, who was recently promoted to an expanded role of chief business officer in addition to his responsibilities as chief financial officer.”
Beer added that Peterson has played an integral role in Biote’s financial strategy, operational scaling, and integration of Asteria Health.
“Bob’s appointment reflects the board’s confidence in Bob, his capacity to take on greater leadership and his deep knowledge of our operations, strategy and growth priorities,” Beer said. “The board is confident he will provide continuity and clear direction as he leads the Company forward.”
Peterson said he was “honored” to lead the company’s team as they strive to become the leading provider of evidence-based therapeutic wellness solutions.
“Over the past 12 months, we’ve strengthened our commercial organization, expanded our sales team, and enhanced our practitioner support,” Peterson said. “Through these initiatives, Biote has laid a solid foundation to support sustainable, long-term profitable growth. The company will continue to advance operational and organizational initiatives already underway to further strengthen scalability, cross-functional execution and long-term growth.”
CEO at pivotal time
Beer thanked Christensen on behalf of the board for his “strong leadership” during a pivotal time as the company strengthened its commercial and operational capabilities.
“Bret’s leadership has been instrumental during this period, and we are grateful for his continued expertise and insights as a member of the board,” Beer said.
Christensen spoke of the reasons behind his stepping down from Biote’s top post.
“It’s been a privilege to lead Biote during such an important period for the company and I’m proud of the progress our team has made,” he said in a statement. “While stepping away as CEO was not an easy decision, after thoughtful consideration, this is the right time for me to return to Utah and prioritize family and personal matters. I remain confident in the company’s strategy, leadership team, and commercial strength and future direction, and I look forward to continuing to support Biote as a member of the board of directors.”
Biote reaffirmed its full year 2026 guidance for revenue above $190 million, Adjusted EBITDA above $38 million, and a return to procedure revenue growth in the second half of this year.
The company said its board has retained an executive search firm to assist with the identification and evaluation of CFO candidates.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
The premium flexible workspace brand aims to bring founders, executives, and high-growth teams into a shared professional community.
-
Anja Krammer has extensive expertise scaling healthcare and medical technology companies, turning breakthrough innovations into commercially successful products across clinical and consumer markets, Dallas-based Spark said.
-
Tracey Brown joins VertexOne—a leading provider of cloud software "designed to revolutionize the customer experience within the energy and utility industry"—with more than two decades of executive leadership experience. Her most recent post was at Vertafore, an Ohio-based global tech company serving the insurance industry.
-
Cuban didn’t hold back at Convergence AI Dallas, where his onstage conversation with Alex Kantrowitz delivered blunt advice and unfiltered insights.
-
Scott Cooke's 23 years at the Plano-based company "has been instrumental in shaping Toyota Financial Services into the strong, customer-focused organization it is today," said TMNA COO Mark Templin. TFS Executive Adviser Alec Hagey assumes the role of president and CEO effective today.
-
Kyle Hogue will continue in his role as president of the Fort Worth-based mechanical contracting company when he takes over the CEO post from Scott Brady, who acquired DynaTen in 2004.
-
Ash Spiegelberg will work with Disruptive's founder and CEO Alex Davis and the global team on refining strategy, investing, and close engagement with portfolio companies and their founders.
-
Cenly Chen has been tapped as CEO and board member of Dallas-based ChronoScale, which was formed recently via a business combination of Applied Digital’s cloud computing business and California-based EKSO Bionics Holdings. It now operates as an independent public company delivering scalable, GPU-based infrastructure optimized for AI training, inference, and high-performance computing.
-
Alena Brenner will oversee all legal, risk management, government affairs, compliance, corporate social responsibility, and insurance functions for the Irving-based company, and serve as the primary legal advisor to the Builders FirstSource board.
-
With 30 years of hospital pharmacy leadership experience, Rick Couldry’s deep expertise will help ensure Omnicell’s solutions reflect real-world clinical and operational needs with the goal of improving outcomes in complex care environments, the Fort Worth-based company said.
